E. Edward Baetge
Keine laufenden Positionen mehr
Profil
Dr. E.
E.
Baetge is a Venture Partner at NanoDimension Management Ltd.
He is on the Board of Directors at Nestlé Health Science SA.
Dr. Baetge was previously employed as a Chief Scientific Officer & Vice President by ViaCyte, Inc., a Principal by Bristol-Myers Squibb Co., a Chief Scientific Officer by CyThera, Inc., a Principal by CytoTherapuetics, Inc., and a Chief Scientific Officer by Modex Therapeutics Ltd.
He received his doctorate degree from Cornell University.
Ehemalige bekannte Positionen von E. Edward Baetge
| Unternehmen | Position | Ende |
|---|---|---|
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Direktor/Vorstandsmitglied | - |
| CytoTherapuetics, Inc. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Modex Therapeutics Ltd. | Corporate Officer/Principal | - |
CyThera, Inc.
 CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von E. Edward Baetge
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 5 |
|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
CyThera, Inc.
CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Commercial Services |
| Modex Therapeutics Ltd. | Commercial Services |
| CytoTherapuetics, Inc. | Finance |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Health Technology |
